Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Migraine Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prescription Drug
1.2.3 OTC Drug
1.3 Market by Application
1.3.1 Global Oral Migraine Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Migraine Drugs Market Perspective (2018-2033)
2.2 Oral Migraine Drugs Growth Trends by Region
2.2.1 Global Oral Migraine Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oral Migraine Drugs Historic Market Size by Region (2018-2023)
2.2.3 Oral Migraine Drugs Forecasted Market Size by Region (2024-2033)
2.3 Oral Migraine Drugs Market Dynamics
2.3.1 Oral Migraine Drugs Industry Trends
2.3.2 Oral Migraine Drugs Market Drivers
2.3.3 Oral Migraine Drugs Market Challenges
2.3.4 Oral Migraine Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Migraine Drugs Players by Revenue
3.1.1 Global Top Oral Migraine Drugs Players by Revenue (2018-2023)
3.1.2 Global Oral Migraine Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Oral Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Migraine Drugs Revenue
3.4 Global Oral Migraine Drugs Market Concentration Ratio
3.4.1 Global Oral Migraine Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Migraine Drugs Revenue in 2022
3.5 Oral Migraine Drugs Key Players Head office and Area Served
3.6 Key Players Oral Migraine Drugs Product Solution and Service
3.7 Date of Enter into Oral Migraine Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Migraine Drugs Breakdown Data by Type
4.1 Global Oral Migraine Drugs Historic Market Size by Type (2018-2023)
4.2 Global Oral Migraine Drugs Forecasted Market Size by Type (2024-2033)
5 Oral Migraine Drugs Breakdown Data by Application
5.1 Global Oral Migraine Drugs Historic Market Size by Application (2018-2023)
5.2 Global Oral Migraine Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oral Migraine Drugs Market Size (2018-2033)
6.2 North America Oral Migraine Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oral Migraine Drugs Market Size by Country (2018-2023)
6.4 North America Oral Migraine Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Migraine Drugs Market Size (2018-2033)
7.2 Europe Oral Migraine Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oral Migraine Drugs Market Size by Country (2018-2023)
7.4 Europe Oral Migraine Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Migraine Drugs Market Size (2018-2033)
8.2 Asia-Pacific Oral Migraine Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oral Migraine Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Oral Migraine Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Migraine Drugs Market Size (2018-2033)
9.2 Latin America Oral Migraine Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oral Migraine Drugs Market Size by Country (2018-2023)
9.4 Latin America Oral Migraine Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Migraine Drugs Market Size (2018-2033)
10.2 Middle East & Africa Oral Migraine Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oral Migraine Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Oral Migraine Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Oral Migraine Drugs Introduction
11.1.4 GSK Revenue in Oral Migraine Drugs Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Oral Migraine Drugs Introduction
11.2.4 Teva Revenue in Oral Migraine Drugs Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oral Migraine Drugs Introduction
11.3.4 Pfizer Revenue in Oral Migraine Drugs Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Oral Migraine Drugs Introduction
11.4.4 Novartis Revenue in Oral Migraine Drugs Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Sun Pharma
11.5.1 Sun Pharma Company Detail
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma Oral Migraine Drugs Introduction
11.5.4 Sun Pharma Revenue in Oral Migraine Drugs Business (2018-2023)
11.5.5 Sun Pharma Recent Development
11.6 Grunenthal
11.6.1 Grunenthal Company Detail
11.6.2 Grunenthal Business Overview
11.6.3 Grunenthal Oral Migraine Drugs Introduction
11.6.4 Grunenthal Revenue in Oral Migraine Drugs Business (2018-2023)
11.6.5 Grunenthal Recent Development
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Detail
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Oral Migraine Drugs Introduction
11.7.4 Endo Pharmaceuticals Revenue in Oral Migraine Drugs Business (2018-2023)
11.7.5 Endo Pharmaceuticals Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Oral Migraine Drugs Introduction
11.8.4 Merck Revenue in Oral Migraine Drugs Business (2018-2023)
11.8.5 Merck Recent Development
11.9 J & J
11.9.1 J & J Company Detail
11.9.2 J & J Business Overview
11.9.3 J & J Oral Migraine Drugs Introduction
11.9.4 J & J Revenue in Oral Migraine Drugs Business (2018-2023)
11.9.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Migraine Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prescription Drug
Table 3. Key Players of OTC Drug
Table 4. Global Oral Migraine Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Oral Migraine Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Oral Migraine Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Oral Migraine Drugs Market Share by Region (2018-2023)
Table 8. Global Oral Migraine Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Oral Migraine Drugs Market Share by Region (2024-2033)
Table 10. Oral Migraine Drugs Market Trends
Table 11. Oral Migraine Drugs Market Drivers
Table 12. Oral Migraine Drugs Market Challenges
Table 13. Oral Migraine Drugs Market Restraints
Table 14. Global Oral Migraine Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Oral Migraine Drugs Market Share by Players (2018-2023)
Table 16. Global Top Oral Migraine Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Migraine Drugs as of 2022)
Table 17. Ranking of Global Top Oral Migraine Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Oral Migraine Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oral Migraine Drugs Product Solution and Service
Table 21. Date of Enter into Oral Migraine Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oral Migraine Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Oral Migraine Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Oral Migraine Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Oral Migraine Drugs Revenue Market Share by Type (2024-2033)
Table 27. Global Oral Migraine Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Oral Migraine Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Oral Migraine Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Oral Migraine Drugs Revenue Market Share by Application (2024-2033)
Table 31. North America Oral Migraine Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Oral Migraine Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Oral Migraine Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Oral Migraine Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Oral Migraine Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Oral Migraine Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Oral Migraine Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Oral Migraine Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Oral Migraine Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Oral Migraine Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Oral Migraine Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Oral Migraine Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Oral Migraine Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Oral Migraine Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Oral Migraine Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Oral Migraine Drugs Product
Table 49. GSK Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 50. GSK Recent Development
Table 51. Teva Company Detail
Table 52. Teva Business Overview
Table 53. Teva Oral Migraine Drugs Product
Table 54. Teva Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 55. Teva Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Oral Migraine Drugs Product
Table 59. Pfizer Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Oral Migraine Drugs Product
Table 64. Novartis Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Sun Pharma Company Detail
Table 67. Sun Pharma Business Overview
Table 68. Sun Pharma Oral Migraine Drugs Product
Table 69. Sun Pharma Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 70. Sun Pharma Recent Development
Table 71. Grunenthal Company Detail
Table 72. Grunenthal Business Overview
Table 73. Grunenthal Oral Migraine Drugs Product
Table 74. Grunenthal Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 75. Grunenthal Recent Development
Table 76. Endo Pharmaceuticals Company Detail
Table 77. Endo Pharmaceuticals Business Overview
Table 78. Endo Pharmaceuticals Oral Migraine Drugs Product
Table 79. Endo Pharmaceuticals Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 80. Endo Pharmaceuticals Recent Development
Table 81. Merck Company Detail
Table 82. Merck Business Overview
Table 83. Merck Oral Migraine Drugs Product
Table 84. Merck Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 85. Merck Recent Development
Table 86. J & J Company Detail
Table 87. J & J Business Overview
Table 88. J & J Oral Migraine Drugs Product
Table 89. J & J Revenue in Oral Migraine Drugs Business (2018-2023) & (US$ Million)
Table 90. J & J Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Migraine Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oral Migraine Drugs Market Share by Type: 2022 VS 2033
Figure 3. Prescription Drug Features
Figure 4. OTC Drug Features
Figure 5. Global Oral Migraine Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Oral Migraine Drugs Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Oral Migraine Drugs Report Years Considered
Figure 11. Global Oral Migraine Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Oral Migraine Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Oral Migraine Drugs Market Share by Region: 2022 VS 2033
Figure 14. Global Oral Migraine Drugs Market Share by Players in 2022
Figure 15. Global Top Oral Migraine Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Migraine Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Oral Migraine Drugs Revenue in 2022
Figure 17. North America Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Oral Migraine Drugs Market Share by Country (2018-2033)
Figure 19. United States Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Oral Migraine Drugs Market Share by Country (2018-2033)
Figure 23. Germany Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Oral Migraine Drugs Market Share by Region (2018-2033)
Figure 31. China Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Oral Migraine Drugs Market Share by Country (2018-2033)
Figure 39. Mexico Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Oral Migraine Drugs Market Share by Country (2018-2033)
Figure 43. Turkey Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Oral Migraine Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 46. Teva Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 49. Sun Pharma Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 50. Grunenthal Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 51. Endo Pharmaceuticals Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 52. Merck Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 53. J & J Revenue Growth Rate in Oral Migraine Drugs Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed